Kristal Robert Eugene 4
4 · BioRestorative Therapies, Inc. · Filed Jun 7, 2022
Insider Transaction Report
Form 4
Kristal Robert Eugene
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-06-07$4.56/sh+200$912→ 7,800 total
Holdings
- 10,490
Stock Option
Exercise: $13.50Exp: 2031-11-04→ Common Stock (10,490 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.